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Do RET somatic mutations play a
role in Hirschsprung disease?
To the Editor: We read “RET Somatic Mutations Are
Underrecognized in Hirschsprung Disease,” by Jiang et al.1,
recently published in your journal, with great interest. The
authors hypothesize a contribution of RET somatic mutations
to Hirschsprung disease (HSCR).
HSCR is a complex inherited disorder characterized by the
absence of enteric ganglia in the distal part of the colon.
Several genes and loci have been described as underlying
disease pathogenesis. However, variants in these genes explain
no more than 20% of all cases.2 This missing heritability seen
in HSCR is a common feature of many complex disorders,
and explaining it remains challenging. Considering that
HSCR develops during embryogenesis as a result of either
impaired migration, proliferation, or differentiation of enteric
neural crest cells (ENCCs), it is tempting to consider that
somatic mutations occurring during the development of the
enteric nervous system, and specifically affecting ENCCs, can
also contribute to HSCR genetics. Jiang and colleagues think
that this is possible, and we share that opinion, as we believe
that somatic variants could be underrecognized in HSCR, and
thus, possibly account for some of the missing heritability.
However, the results described by the authors do not, in our
opinion, fully support the conclusions of the manuscript. This
is mainly because routine genetic testing on DNA derived
from blood or saliva would not find these ENCC-specific
mutations, nor would it easily detect low mosaic variants.
With this letter, we intend to further discuss our concerns and
highlight the difference between causative somatic mutations
and germ-line mosaicism resulting in seemingly de novo
mutations in the next of kin.
In their study, the authors screened 152 HSCR patients
using targeted exome sequencing and direct gene screening.
In eight patients they identified putative deleterious de novo
variants in RET. Because RET is the major HSCR-causing
gene,3 they assumed that these variants were responsible for
the disease phenotype. However, only six patients carried a
truly de novo RET mutation; in the other two, the variants
identified were also found in one of the parents. The authors
continued the genetic analysis of the six remaining patients
and determined, based on their findings, that the RET
mutations identified were somatic. This result led to the
conclusion that RET somatic mosaicism is present in 75% of
these HSCR cases and is, therefore, underrecognized. How-
ever, in four of the six patients studied, germ-line mosaicism
was identified in the parents. As these variants are transmitted
to the affected next of kin as heterozygous variants, they
cannot represent somatic mosaicism. In addition, the parents
are not affected, leading us to speculate that either their
ENCCs are not affected by the mutation or that the
mutational load in their ENCCs does not cross a threshold
for abnormal ENS development. Therefore, although these
four families are likely to represent germ-line mosaicism
resulting in seemingly de novo mutations in the next of kin,
they do not support the conclusion that RET somatic
mutations are underrecognized. These heterozygous muta-
tions would be detected (and are detected in these patients) in
routine genetic screening and as such do not resolve missing
heritability due to “recognizing” somatic mosaicism.
For the remaining two patients, the RET variants identified
were present in blood, saliva, and colon, in family 1 (39/39/
44%) and family 2 (44/35/39%). The authors validated the
sequencing data with TA cloning, but the results are variable
even within the same tissue, and the differences seen in the
amplicon-based sequencing test are well within the normal
range for detection of a heterozygous variant. Moreover, the
samples tested—blood, saliva, and colon—derive from tissues
originating from different germ layers. Blood, mostly
lymphocytes, is derived from mesoderm; saliva, lymphocytes,
and epithelial lining of the mouth are derived from mesoderm
and ectoderm; and the colon has contributions from all three
germ layers. The high allele frequencies identified in all
three samples for both patients (>30%) does not allow for
discrimination between very early developmental stage
somatic mutations or de novo variants present as a germ-
line mosaicism in one of the parents. Although the authors
acknowledge this fact in the discussion, it is more fitting to
conclude that the variants identified in these two remaining
patients are likely to be de novo heterozygous variants.
In conclusion, we agree with the hypothesis of Jiang et al.
and think that somatic variants might well play a role in
HSCR development. However, based on the results presented
we think that it is not possible to make such a conclusion, as
no true somatic RET mutations were identified in any of the
presented patients. We believe that to draw the conclusions
stated, the allele frequency of the mutations in ENCCs,
surface ectoderm, and, for instance, blood or fibroblasts
would need to be compared because these represent different
germ layers and include the cells involved in HSCR. An
experimental setup that would isolate cells specifically from
each germ layer, as well as ENCCs, or that would separate the
colon into various cell types, would be necessary to determine
whether true somatic mutations impact HSCR development.
Only if differences were found under such conditions could
the authors show that RET somatic mutations are indeed
underrecognized in HSCR.
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